TY  -  
T1  - Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study 
SN  -  /  
UR  - http://hdl.handle.net/10138/299657 
T3  -  
A1  - PRIAS Study Grp; Drost, Frank-Jan H.; Rannikko, Antti; Valdagni, Riccardo; Pickles, Tom; Kakehi, Yoshiyuki; Remmers, Sebastiaan; van der Poel, Henk G.; Bangma, Chris H.; Roobol, Monique J. 
A2  -  
PB  -  
Y1  - 2018 
LA  - eng 
AB  - Background: Active surveillance (AS) for low-risk prostate cancer (PCa) appears to provide excellent long-term PCa-specific and overall survival. The choice for AS as initial treatment is mainly based on avoiding side effects from invasive treatment; but AS entails regular check-ups and the possibility of still having to switch or deciding to switch to invasive treatment. Here, we assessed the long-term follow-up data from AS in real life clinical practices. Methods: Data from the first 500 men,... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Active surveillance (AS); prostate-specific antigen screening; overdiagnosis; overtreatment; low-risk prostate cancer; limitations; 2014 INTERNATIONAL SOCIETY; TERM OUTCOMES; FOLLOW-UP; BIOPSY; COHORT; MEN; MORTALITY; STATEMENT; TRIAL; 3126 Surgery, anesthesiology, intensive care, radiology; 3122 Cancers; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -